Duarte-Duran , A. S., Arango-Moreno, F., Palomino-Mendoza , K. D., Rincón-Lozano, Z. Y., Rojas-Torres, L. D., Buvoli-Macareno , G., . . . Ortega-Sierra, M. G. (2024). Proton pump inhibitors vs. histamine receptor 2 antagonists in gastric protection in the anticoagulated patient: What has the evidence defined?
Citación estilo ChicagoDuarte-Duran , Angie S., Federico Arango-Moreno, Karen D. Palomino-Mendoza , Zaira Y. Rincón-Lozano, Laura D. Rojas-Torres, Gianfranco Buvoli-Macareno , Angélica M. Rodríguez-López, y Michael G. Ortega-Sierra. Proton Pump Inhibitors Vs. Histamine Receptor 2 Antagonists in Gastric Protection in the Anticoagulated Patient: What Has the Evidence Defined? 2024.
Cita MLADuarte-Duran , Angie S., et al. Proton Pump Inhibitors Vs. Histamine Receptor 2 Antagonists in Gastric Protection in the Anticoagulated Patient: What Has the Evidence Defined? 2024.